Common Stock, Shares, Issued of BioScience Health Innovations, Inc. from 31 Aug 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
BioScience Health Innovations, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Aug 2019 to 30 Sep 2025.
  • BioScience Health Innovations, Inc. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 10,979,055, a 74% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

BioScience Health Innovations, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 10,979,055 -31,117,166 -74% 30 Sep 2025 10-Q 27 Oct 2025 2025 Q3
Q2 2025 43,916,221 +2,320,000 +5.6% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 43,916,221 +2,320,000 +5.6% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 10,979,055 -29,917,166 -73% 31 Dec 2024 10-Q 27 Oct 2025 2025 Q3
Q3 2024 42,096,221 +1,303,621 +3.2% 30 Sep 2024 10-Q 28 Oct 2024 2024 Q3
Q2 2024 41,596,221 +1,283,621 +3.2% 30 Jun 2024 10-Q 30 Jul 2024 2024 Q2
Q1 2024 41,596,221 +1,763,621 +4.4% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 40,896,221 +35,434,721 +649% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 40,792,600 +35,331,100 +647% 30 Sep 2023 10-Q 31 Oct 2023 2023 Q3
Q2 2023 40,312,600 +34,851,100 +638% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 39,832,600 +34,371,100 +629% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 5,461,500 0 0% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 5,461,500 0 0% 31 Aug 2022 10-Q 17 May 2024 2023 Q2
Q2 2022 5,461,500 0 0% 31 May 2022 10-Q 13 Jul 2022 2022 Q3
Q1 2022 5,461,500 0 0% 28 Feb 2022 10-Q 14 Apr 2022 2022 Q2
Q4 2021 5,461,500 0 0% 30 Nov 2021 10-Q 14 Jan 2022 2022 Q1
Q3 2021 5,461,500 0 0% 31 Aug 2021 10-K 01 Nov 2022 2022 FY
Q2 2021 5,461,500 0 0% 31 May 2021 10-Q 14 Jul 2021 2021 Q3
Q1 2021 5,461,500 +2,391,500 +78% 28 Feb 2021 10-Q 13 Apr 2021 2021 Q2
Q4 2020 5,461,500 +2,661,500 +95% 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 5,461,500 +2,661,500 +95% 31 Aug 2020 10-K 26 Nov 2021 2021 FY
Q2 2020 5,461,500 31 May 2020 10-Q 13 Jul 2020 2019 Q3
Q1 2020 3,070,000 29 Feb 2020 10-Q 14 Apr 2020 2019 Q2
Q4 2019 2,800,000 30 Nov 2019 10-Q 13 Feb 2020 2019 Q1
Q3 2019 2,800,000 31 Aug 2019 10-K 25 Nov 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.